TickerFacts.

Compare

CalciMedica, Inc. vs Edesa Biotech, Inc. vs Chemomab Therapeutics Ltd. vs CytoDyn Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearCalciMedica, Inc.
CALC		Edesa Biotech, Inc.
EDSA		Chemomab Therapeutics Ltd.
CMMB		CytoDyn Inc.
CYDY
Year ended2025-12-312025-09-302025-12-312026-05-31
Revenuen/an/an/an/a
Revenue growth (YoY)n/an/an/an/a
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$29.56M-$7.19M-$8.99M-$42.70M
EPS (Diluted)-$1.97n/a$0.018-$0.03
Operating cash flow-$21.18M-$7.32M-$11.13M-$17.25M
Free cash flow-$21.21Mn/a-$11.13Mn/a
Cash & equivalents$11.52M$10.80M$7.56M$11.85M
Total assets$13.59M$13.53M$13.81M$13.97M
Total liabilities$20.23Mn/a$1.48M$123.69M
Shareholders' equity-$6.64M$12.45M$12.33M-$109.72M
Return on year-end equityn/a-57.7%-72.9%n/a
Shares outstanding15.44M7.14Mn/a1.37B

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearCalciMedica, Inc.Edesa Biotech, Inc.Chemomab Therapeutics Ltd.CytoDyn Inc.
Latestn/a$0
Ended 2021-09-30		n/a$0
Ended 2023-05-31
1 year earliern/a$328.8K
Ended 2020-09-30		n/a$266.0K
Ended 2022-05-31
2 years earliern/an/an/a$0
Ended 2021-05-31
3 years earliern/a$211.8K
Ended 2018-09-30		n/an/a
4 years earliern/a$228.3K
Ended 2017-09-30		n/an/a